Publications
- Home
- Publications
TTANGO, TTANGO2 and TTANGO3 Publications and Conference Contributions
2024
2023
2021
2019
2018
2017
2016
2015
2014
2013
Monaghan R and King J, et al. (Poster). 25th IUSTI World Congress incorporating the Australasian Sexual and Reproductive Health Conference, Sydney, 17-20 September 2024
Causer L and Riessen J, et al. (Poster). 25th IUSTI World Congress incorporating the Australasian Sexual and Reproductive Health Conference, Sydney, 17-20 September 2024
25th IUSTI World Congress incorporating the Australasian Sexual and Reproductive Health Conference, Sydney, 17-20 September 2024
Watts C, et al. (Oral presentation). 25th IUSTI World Congress incorporating the Australasian Sexual and Reproductive Health Conference, Sydney, 17-20 September 2024
Monaghan R and King J, et. al. (Oral) Communicable Diseases & Immunisation Conference 2024, Brisbane, 11-13 June 2024
Causer L and Riessen J, et al. (Oral) Communicable Diseases & Immunisation Conference 2024, Brisbane, 11-13 June 2024
Integration of Molecular Point-of-Care Testing (POCT) for infectious diseases in community settings
Kayago, et al. (Oral) CDIC Communicable Diseases & Immunisation Conference 2024, Brisbane, 11-13 June 2024
Causer LM, Ward J, Smith K, Saha A, Andrewartha K, Wand H, Hengel, B, Badman SG, Tangey A, Matthews S, Mak D, Gunathilake M, Moore E, Speers D, Persing D, Anderson D, Whiley D, Maher L, Regan D, Donovan B, Fairley C, Kaldor J, Shephard M, and Guy R, on behalf of the TTANGO2 Collaboration. June 10, 2024
Dr Louise Causer et al., abstract from ASRH September 18-20, 2023
Annie Tangey et al., abstract from ASRH September 18-20, 2023
STI &HIV 2023 World Congress, Chicago July 24 – 27, 2023
Caroline Watts et al., abstract from IHEA, July 10, 2023
An innovative connectivity solution for national decentralised infectious diseases testing programs in regional and remote primary health services in Australia (oral abstract)
Saha et al. 1st Australasian Conference on Point of Care Testing for Infectious Diseases (POC 2023), Sydney (March 2023) https://az659834.vo.msecnd.net/eventsairaueprod/production-ashm-public/f0ada0a8fe9a467690623e9ffe9a0bca
Acceptability among healthcare workers and clinic managers on the uptake of molecular point-of-care testing for Trichomonas vaginalis
Tangey et al. (poster abstract) 1st Australasian Conference on Point of Care Testing for Infectious Diseases (POC 2023), Sydney (March 2023) https://az659834.vo.msecnd.net/eventsairaueprod/production-ashm-public/5f7274a1289444a4ad6167ea2cc170d5
Assessment of the training and quality systems for the TTANGO3 (Test, Treat And GO) sexually transmitted infection (STI) point-of-care testing network
Shephard et al. (oral abstract) 1st Australasian Conference on Point of Care Testing for Infectious Diseases (POC 2023), Sydney (March 2023) https://az659834.vo.msecnd.net/eventsairaueprod/production-ashm-public/4f4f5e4d372c46c79a6a52c5649f8413
A flexible and innovative connectivity solution to support national decentralised infectious diseases point-of-care testing programs in primary health services in Australia
Saha, A., Andrewartha, K., Badman, S., Tangey, A., Smith, K., Sandler, S., Ramsay, S., Braund, W., Margison, S. M., Matthews, S., Shephard, M., Guy, R., Causer., L. A flexible and innovative connectivity solution to support national decentralised infectious diseases point-of-care testing programs in primary health services in Australia. JMIR Preprints (2023). http://doi.org/10.2196/preprints.46701
Scaling up sexually transmissible infections point-of-care testing in remote Aboriginal and Torres Strait Islander communities: healthcare workers' perceptions of the barriers and facilitators.
Lafferty, L., Smith, K., Causer, L., Andrewartha, K., Whiley, D., Badman, S. G., Donovan, B., Anderson, L., Tangey, A., Mak, D., Maher, L., Shephard, M., Guy, R. Scaling up sexually transmissible infections point-of-care testing in remote Aboriginal and Torres Strait Islander communities: healthcare workers' perceptions of the barriers and facilitators. Implement Sci Commun 2, 127 (2021). https://doi.org/10.1186/s43058-021-00232-8
From trial to program: TTANGO2 scale-up and implementation sustains STI point-of-care testing in regional and remote Australian Aboriginal health services (poster abstract).
L. Causer et al. STI and HIV World Congress (virtual conference), (July 2021) http://dx.doi.org/10.1136/sextrans-2021-sti.269
The Cost-Effectiveness and Impact of Molecular Point of Care Testing for Chlamydia and Gonorrhea on the Reproductive Health of Indigenous Women in Remote Australian Communities (oral abstract).
C.Watts et al. International Health Economics Association Congress (virtual conference), (July 2021) https://healtheconomics.confex.com/healtheconomics/2021/meetingapp.cgi/Paper/5892
The cost-effectiveness of molecular point of care testing for chlamydia and gonorrhoea in remote communities (oral abstract).
C. Watts et al. Health Services Research Association of Australia and New Zealand (HSRAANZ) conference, Auckland NZ (December 2019) https://az659834.vo.msecnd.net/eventsairaueprod/production-ashm-public/97ab2b27023840709bfc28b4cecf95b4
Presumptive treatment for chlamydia and gonorrhoea in remote Aboriginal health services (oral presentation).
K. Smith et al. ASHM conference, Perth (September 2019). https://az659834.vo.msecnd.net/eventsairaueprod/production-ashm-public/bc01c05cea164ba2a3146f4c85289b8a
Sustainability of point-of-care testing for sexually transmissible infections in remote communities in Australia – transition from trial to program (oral abstract).
R. Guy et al. IUSTI conference, New Zealand (November 2018). https://az659834.vo.msecnd.net/eventsairaueprod/production-ashm-public/451e41a668454a07885fb681b1f97529
Molecular point-of-care testing for chlamydia and gonorrhoea in Indigenous Australians attending remote primary health services (TTANGO): a cluster-randomised, controlled, crossover trial.
R. Guy et al. The Lancet Infectious Diseases (October 2018). https://pubmed.ncbi.nlm.nih.gov/30303108/
The TTANGO Trial Final Report To Health Services May 2018
Molecular testing for chlamydia and gonorrhoea used at point-of-care in remote primary health care settings: a diagnostic evaluation.
Causer LM, Guy RJ, Tabrizi SN, Whiley D, Speers D, Ward J, Tangey A, Badman SG, Hengel B, Natoli L, Anderson DA, Wand H, Wilson D, Regan DG, Shephard M, Donovan B, Fairley CK, Kaldor JM. Molecular testing for chlamydia and gonorrhoea used at point-of-care in remote primary health care settings: a diagnostic evaluation. Sexually Transmitted Infections (accepted 2018). https://doi.org/10.1136/sextrans-2017-053443
A reliable and easy to transport quality control method for chlamydia and gonorrhoea molecular point of care testing.
Badman SG, Causer LM, Guy R, Wand H, Donovan B, Tabrizi S, Speers D, Shephard MD, Vallely A, Whiley D on behalf of the TTANGO investigators. A reliable and easy to transport quality control method for chlamydia and gonorrhoea molecular point of care testing. Pathology 2018;50: 317-321. https://doi.org/10.1016/j.pathol.2017.09.012
Translating the TTANGO Trial into Routine Practice - Poster Presented at National Rural Health Conference April 2017
A preliminary evaluation of a new GeneXpert (Gx) molecular point-of-care test for the detection of Trichomonas vaginalis.
Badman SG, Causer LM, Guy R, Tabrizi S, Francis F, Donovan B, Whiley D on behalf of the TTANGO Investigators (including Shephard M). A preliminary evaluation of a new GeneXpert (Gx) molecular point-of-care test for the detection of Trichomonas vaginalis. Sexually Transmitted Infections 2016; 92: 350-352. http://dx.doi.org/10.1136/sextrans-2015-052384
A Qualitative Study of the Acceptability of Molecular Point-Of-Care Testing for Chlamydia and Gonorrhoea to Primary Care Professionals in a Remote High STI Burden Setting.
Natoli L, Guy RJ, Shephard M, Causer L, Badman SG, Hengel B, et al. “I Do Feel Like a Scientist at Times”: A Qualitative Study of the Acceptability of Molecular Point-Of-Care Testing for Chlamydia and Gonorrhoea to Primary Care Professionals in a Remote High STI Burden Setting. PLoS ONE 2015; 10(12): e0145993. http://dx.doi.org/10.1371/journal.pone.0145993
Public health implications of molecular point-of-care testing for chlamydia and gonorrhoea in remote primary care services in Australia: a qualitative study.
Natoli L, Guy RJ, Shephard M, Whiley D, Tabrizi SN, Ward J, Regan DG, Badman SG, Anderson DA, Kaldor J, Maher L on behalf of the TTANGO investigator group. Public health implications of molecular point-of-care testing for chlamydia and gonorrhoea in remote primary care services in Australia: a qualitative study. BMJOpen 2015; 5:e006922. http://doi:10.1136/bmjopen-2014-006922
Chlamydia and gonorrhoea point-of-care testing in Australia: where should it be used?
Natoli L, Guy RJ, Shephard M, Donovan B, Fairley C, Ward J, Regan D, Hengel B, Maher L on behalf of the TTANGO Investigators. Chlamydia and gonorrhoea point-of-care testing in Australia: where should it be used? Sexual Health 2015; 12: 51-58. http://dx.doi.org/10.1071/SH14213
A field evaluation of a new molecular-based point-of-care test for chlamydia and gonorrhoea in remote Aboriginal health services in Australia
Louise Causer, Belinda Hengel, Lisa Natoli, Annie Tangey, Steven Badman, Sepehr Tabrizi, David Whiley, James Ward, John Kaldor, Rebecca Guy and on behalf of the TTANGO investigators; 27 November 2014 https://pubmed.ncbi.nlm.nih.gov/25426655/
Point-of-care testing for chlamydia and gonorrhoea: implications for clinical practice.
Natoli L, Maher L, Shephard M, Hengel B, Tangey A, Badman S, Ward J, Guy R on behalf of the TTANGO investigators. Point-of-care testing for chlamydia and gonorrhoea: implications for clinical practice. PLoS ONE 2014; 9(6): e100518. http://dx.doi.org/10.1371/journal.pone.0100518
A randomised trial of point-of-care tests for chlamydia and gonorrhoea infections in remote communities: Test, Treat And GO- the ‘TTANGO’ trial protocol.
Guy R, Natoli l, Ward J, Causer L, Hengel B, Whiley D, Tabrizi S, Donovan B, Fairley C, Badman S, Tangey A, Wand H, Shephard M, Regan D, Wilson D, Anderson D, Kaldor J. A randomised trial of point-of-care tests for chlamydia and gonorrhoea infections in remote communities: Test, Treat And GO- the ‘TTANGO’ trial protocol. BMC Infectious Diseases 2013; 13: 485. http://doi:10.1186/1471-2334-13-485
Analytical evaluation of GeneXpert CT/NG, the first genetic point-of-care assay for simultaneous detection of Neisseria gonorrhoeae and Chlamydia trachomatis.
Tabrizi S, Unemo M, Golparian D, Twin J, Limnios A, Lahra M, Guy R, Ward J, Kaldor J, Donovan B, Wilson D, Wand H, Regan, D, Causer L, Hengel B, Natoli L, Anderson D, Whiley D, Shephard M, Fairley, C. Analytical evaluation of GeneXpert CT/NG, the first genetic point-of-care assay for simultaneous detection of Neisseria gonorrhoeae and Chlamydia trachomatis. Journal of Clinical Microbiology 2013; 51: 1945-1947. https://doi.org/10.1128/jcm.00806-13